Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  yttrium Y 90 anti-CD45 monoclonal antibody BC8
Find trials that include:  Any drugs shown
Results 1-4 of 4 for your search:
Start Over
Radiolabeled Monoclonal Antibody and Combination Chemotherapy before Stem Cell Transplant in Treating Patients with High-Risk Lymphoid Malignancies
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2728.00, NCI-2013-01378, NCT01921387
Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients with High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 50 and over
Trial IDs: 2468.00, NCI-2011-00150, 2468, 2468.00A, NCT01300572
Monoclonal Antibody Therapy before Stem Cell Transplant in Treating Patients with Relapsed or Refractory Lymphoid Malignancies
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2361.00, NCI-2012-01505, NCT01678443
Start Over